Global Resistance of Neisseria gonorrhoeae

When Theory Becomes Reality

David A. Lewis

Disclosures

Curr Opin Infect Dis. 2014;27(1):62-67. 

In This Article

Antimicrobial Treatment Options in Development

Despite the need for new antimicrobial treatment options, no such agents are in the late development stage. Pleuromutilins, novel inhibitors of bacterial topoisomerases and efflux pumps, FabI inhibitors and LpxC inhibitors are among compounds that may potentially be exploited to improve the management of MDR/XDR gonorrhoea in the future.[2]

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....